Sign Up Today and Learn More About PhotoPharmics Stock
Invest in or calculate the value of your shares in PhotoPharmics or other pre-IPO companies through EquityZen's platform.
PhotoPharmics Stock
PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.
About PhotoPharmics Stock
Founded
2011
Headquarters
Lehi, UT, US
Industries
Software, Artificial Intelligence, Data and Analytics
PhotoPharmics Press Mentions
Stay in the know about the latest news on PhotoPharmics
PhotoPharmics closes $6 million to advance Parkinson’s device
longevity • Apr 28, 2025
PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device
vcaonline • Apr 22, 2025
PhotoPharmics Closes $6 Million Series B Extension to Advance Light-Based Therapy
techbuzznews • Apr 19, 2025
PhotoPharmics Closes Oversubscribed $6 Million Series B Extension to Advance FDA Breakthrough Parkinson’s Device
einpresswire • Apr 18, 2025
Ocular treatments for neurological and neuropsychiatric disorders
patents • Apr 02, 2025
PhotoPharmics Management
Leadership team at PhotoPharmics
Chief Medical Officer
Karl Kieburtz
Co-founder and CEO
Kent Savage
Join now and verify your accreditation status to gain access to:
- PhotoPharmics Current Valuation
- PhotoPharmics Stock Price
- PhotoPharmics Management
- Available deals in PhotoPharmics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- PhotoPharmics Cap Table and Funding History by Share Class and Liquidity Preferences
- PhotoPharmics Revenue and Financials
- PhotoPharmics Highlights
- PhotoPharmics Business Model
- PhotoPharmics Risk Factors
- PhotoPharmics Research Report from SACRA Research
Trading PhotoPharmics Stock
How to invest in PhotoPharmics stock?
Accredited investors can buy pre-IPO stock in companies like PhotoPharmics through EquityZen funds. These investments are made available by existing PhotoPharmics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell PhotoPharmics stock?
Shareholders can sell their PhotoPharmics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."